Healthcare / Drug Manufacturers - GeneralUpdated 2026-05-10 22:07 UTC

SWX/RO stock hub

SWX/RO has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SWX/ROis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

251.7B

SIX Swiss Exchange

Market data

Live price

Current market quote for this ticker.

Current price

SWX/RO

In the news

Latest news · SWX/RO

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E15.3

P25 15.9P50 20.7P75 33.1

Trailing P/E19.5

P25 19.6P50 21.4P75 37.6

ROE37.3

P25 -6.1P50 7.9P75 17

ROIC30.7

P25 -4.4P50 6.6P75 15.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SWX/RO market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

244

Groups with data

Currency

CHF

Showing 244 of 244 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Switzerland
Country code	CH
Employees	103,249
Employees Change	-356%
Employees Change Percent	-0.34
Enterprise value	CHF 273.5B
Exchange	SIX Swiss Exchange
Financial currency	CHF
First seen	2026-05-10
Industry	Drug Manufacturers - General
Isin	CH0012032113
Last refreshed	2026-05-10
Market cap	CHF 251.7B
Price	CHF 323
Price currency	CHF
Rev Per Employee	613,623.38x
Sector	Healthcare
Sic	2834
Symbol	swx/RO
Website	https://www.roche.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	5.12%
EV Earnings	21.23x
EV/EBIT	13.07x
EV/EBITDA	11.25x
EV/FCF	18.11x
EV/Sales	4.32x
FCF yield	6%
Forward P/E	15.26x
P/B ratio	6.64x
P/E ratio	19.54x
P/S ratio	3.97x
PE Ratio10 Y	20.24x
PE Ratio3 Y	22.52x
PE Ratio5 Y	20.59x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	33.08%
EBITDA Margin	37.95%
FCF margin	23.84%
Gross margin	74.49%
Gross Profit	CHF 47.2B
Gross Profit Growth	-0.6%
Gross Profit Growth Q	-1.22%
Gross Profit Growth3 Y	1.48%
Gross Profit Growth5 Y	0.43%
Net Income	CHF 12.9B
Net Income Growth	55.61%
Net Income Growth Q	170.93%
Net Income Growth Quarters	2%
Net Income Growth Years	1%
Net Income Growth3 Y	6.65%
Net Income Growth5 Y	3.15%
Pretax Margin	26.79%
Profit Margin	20.33%
Profit Per Employee	CHF 124,747
Profitable Years	23
ROA	12.94
Roa5y	13.31
ROCE	28.83
ROE	37.27
Roe5y	38.06
ROIC	30.65
Roic5y	32.56

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	6.45%
Cagr15y	8.31%
Cagr1y	16.89%
Cagr20y	5.52%
Cagr3y	5.11%
Cagr5y	3.32%
Div CAGR10	2.79%
Div CAGR3	4%
Div CAGR5	3.03%
EPS Growth	55.58
EPS Growth Q	171.3
EPS Growth Quarters	2
EPS Growth Years	1
EPS Growth3 Y	6.61
EPS Growth5 Y	3.23
FCF Growth	-8.82%
FCF Growth Q	-6.66%
FCF Growth3 Y	6.84%
FCF Growth5 Y	3%
OCF Growth	-6.18%
OCF Growth Q	-3.51%
OCF Growth10 Y	0.15%
OCF Growth3 Y	5.38%
OCF Growth5 Y	2.66%
Revenue Growth	1.54x
Revenue Growth Q	-0.42x
Revenue Growth Years	0x
Revenue Growth3 Y	1.5x
Revenue Growth5 Y	0.26x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CHF 0.63
Assets	CHF 100.7B
Cash	CHF 15.5B
Current Assets	CHF 38.7B
Current Liabilities	CHF 28B
Debt	CHF 33.2B
Debt EBITDA	CHF 1.36
Debt Equity	CHF 0.88
Debt FCF	CHF 2.2
Equity	CHF 37.9B
Interest Coverage	17.66
Liabilities	CHF 62.8B
Long Term Assets	CHF 62B
Long Term Liabilities	CHF 34.8B
Net Cash	CHF -17.7B
Net Cash By Market Cap	CHF -7.04
Net Debt EBITDA	CHF 0.74
Net Debt Equity	CHF 0.47
Net Debt FCF	CHF 1.17
Tangible Book Value	CHF 7B
Tangible Book Value Per Share	CHF 8.78
WACC	5.7

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.38
Inventory Turnover	2.14
Net Working Capital	CHF -235M
Quick ratio	1.05
Working Capital	CHF 10.7B
Working Capital Turnover	CHF 5.34

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.13%
Dividend Growth	11.33%
Dividend Growth Years	28%
Dividend per share	CHF 10.8
Dividend Years	35
Dividend Yield	3.33%
Ex Div Date	2026-03-12
Last Dividend	CHF 10.8
Payout Frequency	Annual
Payout Ratio	60.02%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	86.81%
1Y total return	16.88%
200-day SMA	314.9
3Y total return	16.13%
50-day SMA	333.7
50-day SMA vs 200-day SMA	50over200
5Y total return	17.74%
All Time High	439.2
All Time High Change	-26.46%
All Time High Date	2022-04-11
All Time Low	40.2
All Time Low Change	703.48%
All Time Low Date	1992-03-12
ATR	6.74
Beta	0.33
Ch YTD	-3.64
High	325.2
High52	383
High52 Date	2026-02-24
High52ch	-15.67%
Low	321.8
Low52	256.4
Low52 Date	2025-08-08
Low52ch	25.98%
Ma50ch	-3.21%
Price vs 200-day SMA	2.56%
RSI	43.59
RSI Monthly	53.93
RSI Weekly	48.05
Sharpe ratio	0.53x
Sortino ratio	1.12
Total Return	3.21%
Tr YTD	-0.49
Tr15y	231.32%
Tr1m	0.75%
Tr1w	-0.55%
Tr3m	-8.56%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CHF 21B
Operating Income Growth	3.35
Operating Income Growth Q	7.74
Operating Income Growth3 Y	5.2
Operating Income Growth5 Y	1.99
Operating margin	33.08

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	652,938,195%
Net Borrowing	-519,000,000
Shares Insiders	17.93%
Shares Institutions	15.4%
Shares Qo Q	0%
Shares Yo Y	0.13%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CHF 14.2B
Average Volume	27,109.7x
Bv Per Share	42.49
CAPEX	CHF -3.7B
Ch10y	35.54
Ch15y	103.1
Ch1m	0.75
Ch1w	-0.55
Ch1y	13.17
Ch20y	54.77
Ch3m	-11.46
Ch3y	4.94
Ch5y	0.37
Ch6m	15.69
Change	-0.98%
Change From Open	-0.43
Close	326.2
Days Gap	-0.55
Depreciation Amortization	3,086,000,000
Dollar Volume	6,716,785
Earnings Date	2026-07-23
EBIT	CHF 21B
EBITDA	CHF 24B
EPS	CHF 16.04
F Score	5
FCF	CHF 15.1B
FCF EV Yield	5.52x
Financing CF	-11,368,000,000
Fiscal Year End	December
Founded	1,896
Goodwill	7,492,000,000
Graham Number	134.46474
Graham Upside	-58.37
Income Tax	CHF 3.2B
Investing CF	-8,543,000,000
Is Primary Listing	0
Last Earnings Date	2026-01-29
Last Report Date	2025-12-31
Last Split Date	2001-05-04
Last Split Type	Forward
Lynch Fair Value	CHF 82.65
Lynch Upside	-74.41
Ma150	328.8
Ma150ch	-1.78%
Ma20	328
Ma20ch	-1.52%
Net CF	-1,393,000,000
Next Earnings Date	2026-07-23
Open	324.4
P FCF Ratio	16.66
P OCF Ratio	13.35
Payment Date	2026-03-16
Position In Range	35.29
Ppne	22,934,000,000
Price Date	2026-05-08
Price EBITDA	CHF 10.47
Ptbv Ratio	36.01
Relative Volume	0.79x
Revenue	63,356,000,000x
SBC By Revenue	1.35x
Share Based Comp	857,000,000
Tax By Revenue	5.01x
Tax Rate	18.7%
Tr20y	192.99%
Tr6m	19.47%
Volume	20,795
Z Score	4.24

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

SWX/RO dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+3.3%

$10.8 annual per share

Payout ratio

+60.0%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+3.0%

28 consecutive years of growth

Total shareholder yield

+3.2%

Next ex-dividend date: 2026-03-12

Performance

SWX/RO stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SWX/RO?

Insider, institutional, and short-interest positioning.

Institutional ownership

+15.4%

Share of float held by funds and institutions

Insider ownership

+17.9%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.1%

Negative means the company is buying back shares.

Technical

SWX/RO momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

43.6

Neutral momentum band

Price vs 200-day MA

+2.6%

50/200-day relationship not available

Beta (5Y)

0.33

Less volatile than the market

Sharpe ratio

0.53

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SWX/RO

Hub-level FAQ points readers to the deeper analysis pages.

What is the current swx/RO stock rating?

swx/RO is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full swx/RO analysis?

The full report lives at /stocks/swx/RO/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for swx/RO?

The latest report frames swx/RO around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the swx/RO page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.